Table 1 Demographics, clinical and paraclinical data of the study population
Age in years (Mean ± SD) | 34.9 ± 9.2 |
Age at disease onset in years (Mean ± SD) | 28.9 ± 10.5 |
Duration to diagnosis in months Median (IQR) | 10 (0–180) |
Disease duration in months Median (IQR) | 52 (8–216) |
Number of relapses (Mean ± SD) | 4.15 ± 2.3 |
Baseline EDSS (Mean ± SD) | 4.7 ± 2.3 |
Last assessed EDSS (Mean ± SD) | 4.3 ± 2.3 |
Co-morbid autoimmune diseases (n) | |
Organ-specific | 15 |
Non-organ specific | 1 |
Family history of immune-mediated diseases (n) | |
Systemic Lupus erythematosus | 2 |
Rheumatoid arthritis | 3 |
Multiple sclerosis | 1 |
MRI cervical spine | |
Normal | 1 |
Lesions < 3 segments | 7 |
Lesions > 3 segments | 46 |
Not done | 16 |
MRI thoracic spine | |
Normal | 3 |
Lesions < 3 segments | 3 |
Lesions > 3 segments | 13 |
Not done | 51 |
MRI brain | |
MS-like lesions (periventricular– Juxta cortical) | 5 |
Non – specific lesions (migraine-like tiny lesions) | 6 |
NMOSD typical lesions | 59 |
CSF (n = 20) | |
Oligoclonal bands | |
Positive | 9 |
Negative | 11 |
IgG index | |
High | 5 |
Normal | 15 |